AstraZeneca/AZN

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1YMAX

About AstraZeneca

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.

Ticker

AZN

Sector

Healthcare

Trading on

LSE

Industry

Pharmaceuticals

CEO

-

Employees

89,900

Headquarters

Cambridge, United Kingdom

AstraZeneca Metrics

BasicAdvanced
£192B
Market cap
39.03
P/E ratio
£3.18
EPS
0.16
Beta
£2.27
Dividend rate
1.83%
Dividend yield
£192B
0.16417
£2.27
0.886
0.701
75.387
92.515
70.56%
8.84%
7.04%
17.29%
39.03
5.14
6.54
-11.46
41.58
1.83%
8.60%
34.08%
19.96%
10.14%
1.18%

What the Analysts think about AstraZeneca

Analyst Ratings

Majority rating from 32 analysts.
Buy

AstraZeneca Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
17.18% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$13B
5.45%
Net income
$2.2B
126.98%
Profit margin
17.18%
115.29%

AstraZeneca Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 8.05%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$2.15
$1.73
$1.45
$2.06
-
Expected
$1.95
$1.62
$1.49
$1.91
$1.97
Surprise
10.01%
6.92%
-2.82%
8.05%
-
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and LSEG. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for AstraZeneca stock?

AstraZeneca (AZN) has a market cap of £192B as of June 15, 2024.

What is the P/E ratio for AstraZeneca stock?

The price to earnings (P/E) ratio for AstraZeneca (AZN) stock is 39.03 as of June 15, 2024.

Does AstraZeneca stock pay dividends?

Yes, the AstraZeneca (AZN) stock pays dividends to shareholders. As of June 15, 2024, the dividend rate is £2.27397 and the yield is 1.83%. AstraZeneca has a payout ratio of 70.56% on a trailing twelve-month basis.

When is the next AstraZeneca dividend payment date?

The next AstraZeneca (AZN) dividend payment date is unconfirmed.

What is the beta indicator for AstraZeneca?

AstraZeneca (AZN) has a beta rating of 0.16. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the AstraZeneca stock price target?

The target price for AstraZeneca (AZN) stock is £131.07, which is NaN% below the current price of £. This is an average based on projections from 28 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell AstraZeneca stock

Buy or sell AstraZeneca stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing